Currently, PVs in two high-penetrance BC genes, mainly BRCA2 but also BRCA1, and other two moderate-penetrance BC genes, PALB2 and CHEK2, are established as genetic risk factors for MBC, with emerging evidence for the ATM gene [44,79]. This evidence concerns the gene CHEK2 and breast cancer.